Phio Pharmaceuticals Corp.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Phio Pharmaceuticals Corp.
Phio Pharmaceuticals Corp is a clinical-stage biopharmaceutical company whose proprietary INTASYL small-interfering RNA gene silencing technology is designed to make immune cells more effective in killing tumor cells. Its pipeline programs are PH-762 and PH-894. The group is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems. It is committed to discovering and developing cancer treatments for patients by creating new pathways toward a cancer-free future. The Company operates with a single operating segment, the Clinical segment, and all assets are located in the United States.
/ 
Frequently asked questions
To buy Phio Pharmaceuticals Corp. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Phio Pharmaceuticals Corp. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Phio Pharmaceuticals Corp. is PHIO:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Phio Pharmaceuticals Corp. has its primary listing on NASDAQ (Small cap). You can trade Phio Pharmaceuticals Corp. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Phio Pharmaceuticals Corp. is available to trade on SaxoInvestor and SaxoTrader. You can buy shares directly and include Phio Pharmaceuticals Corp. as part of a broader investment portfolio.
Learn more about investing and trading in Saxo's education hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures—so you can make more informed decisions when considering shares like Phio Pharmaceuticals Corp. or others.